Cargando…
Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are required to limit myocardial infarct (MI) size, prevent adverse left ventricular (LV) remodeling, and reduce the onset of heart failure following...
Autores principales: | Ong, Sang-Bing, Hernández-Reséndiz, Sauri, Crespo-Avilan, Gustavo E., Mukhametshina, Regina T., Kwek, Xiu-Yi, Cabrera-Fuentes, Hector A., Hausenloy, Derek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981007/ https://www.ncbi.nlm.nih.gov/pubmed/29330085 http://dx.doi.org/10.1016/j.pharmthera.2018.01.001 |
Ejemplares similares
-
Mitochondria in acute myocardial infarction and cardioprotection
por: Ramachandra, Chrishan J.A., et al.
Publicado: (2020) -
Targeting Mitochondrial Fission Using Mdivi-1 in A Clinically Relevant Large Animal Model of Acute Myocardial Infarction: A Pilot Study
por: Ong, Sang-Bing, et al.
Publicado: (2019) -
Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
por: Dongworth, Rachel K., et al.
Publicado: (2017) -
Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016) -
Targeting mitochondrial shape: at the heart of cardioprotection
por: Hernandez-Resendiz, Sauri, et al.
Publicado: (2023)